SOD1 and COVID-19: Studies assessing panels of OS biomarkers (e.g., thiobarbituric acid reactive substances (TBARS) as a proxy for MDA) alongside antioxidant defences (SOD, CAT, GR) revealed a pronounced imbalance in COVID-19 patients (Pavlova et al., 2025).